Back to Search
Start Over
Clinical Evaluation and Investigations of Atrial Fibrillation in Rheumatic Mitral Valve Disease: An Observational Study in a Tertiary Care Hospital in Western India.
- Source :
- Apollo Medicine; Jun2024, Vol. 21 Issue 2, p101-106, 6p
- Publication Year :
- 2024
-
Abstract
- Background: Atrial fibrillation (AF) is the most common sustained supraventricular arrhythmia encountered in clinical practice. Due to the higher prevalence of rheumatic fever in several regions of India, rheumatic heart disease (RHD) is the most common etiological factor of AF. Aims and Objectives: The objective of the study was to study clinical features, electrocardiographic (ECG) and echocardiographic (ECHO) findings, complications, and incidence of AF in rheumatic mitral valve disease (R-MVD). Methods: It is an observational cross-sectional study of 40 indoor patients in a Tertiary Care Hospital in Vadodara, Gujarat, carried over a period of a year. Clinical data including symptoms, signs, systemic examination, and relevant investigations were studied. Results: 67.5% (n = 27) of patients having AF were below the age of 50 years with higher incidence among females (72.50%) as compared to males (27.5%). Fifteen (37.5%) had mitral stenosis (MS) and 13 (32.5%) had MS with regurgitation. Most of the patients 35 (87.5%) presented with breathlessness, followed by palpitation 28 (70%). The most commonly heard murmur was mid-diastolic (65%, n = 26), followed by pansystolic murmur (40%, n = 16) at the apex. Out of 40 patients, 15 (37.5%) had evidence of left ventricular hypertrophy on ECG, whereas only 5 (12.5%) had right ventricular hypertrophy. Four out of five patients with the evidence of cardioembolic stroke had left atrium (LA) size >45 mm which suggests an increased risk of embolic stroke with increased LA size. Only 3 (7.5%) patients had a visible LA clot in LA on two-dimensional ECHO, whereas only one patient had vegetation on valves. Twenty-seven out of 30 patients treated with diltiazem show good response. Heart failure was the most common complication affecting 85% (n = 34) of the patients with AF with R-MVD. Four (10%) patients out of 40 expired including 1 (25%) of the four pregnant patients, suggesting higher mortality among pregnant females due to superimposed physiological changes occurring during pregnancy. Conclusion: In developing countries like India, RHD is a major cause of AF affecting the younger population and more commonly females. Most of the patients in our study presented with breathlessness and palpitation. LA size was directly proportional to the risk of cardioembolic stroke and most of the patients developed heart failure as a complication. [ABSTRACT FROM AUTHOR]
- Subjects :
- WARFARIN
ATRIAL fibrillation treatment
ATRIAL fibrillation risk factors
RISK assessment
CROSS-sectional method
MITRAL stenosis
JUGULAR vein
HEART murmurs
VENOUS pressure
ASCITES
BUNDLE-branch block
CHEST pain
LOW-molecular-weight heparin
THERAPEUTIC embolization
SCIENTIFIC observation
EDEMA
JAUNDICE
PULMONARY artery
SYMPTOMS
TREATMENT effectiveness
TERTIARY care
HOSPITALS
DESCRIPTIVE statistics
AMIODARONE
HEART failure
MITRAL valve diseases
ELECTROCARDIOGRAPHY
MITRAL valve insufficiency
LEFT ventricular hypertrophy
ENOXAPARIN
ATRIAL fibrillation
RIGHT ventricular hypertrophy
DIGOXIN
STROKE
PULSE (Heart beat)
BLOOD pressure
COUGH
HEMOPTYSIS
DEVELOPING countries
RHEUMATIC heart disease
ECHOCARDIOGRAPHY
DISEASE incidence
DISEASE risk factors
DISEASE complications
PREGNANCY
Subjects
Details
- Language :
- English
- ISSN :
- 09760016
- Volume :
- 21
- Issue :
- 2
- Database :
- Supplemental Index
- Journal :
- Apollo Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 176657216
- Full Text :
- https://doi.org/10.4103/am.am_97_23